Ptc Therapeutics (PTCT) Invested Capital: 2012-2025
Historic Invested Capital for Ptc Therapeutics (PTCT) over the last 13 years, with Sep 2025 value amounting to -$139.2 million.
- Ptc Therapeutics' Invested Capital rose 86.56% to -$139.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$139.2 million, marking a year-over-year increase of 86.56%. This contributed to the annual value of -$1.1 billion for FY2024, which is 35.21% down from last year.
- As of Q3 2025, Ptc Therapeutics' Invested Capital stood at -$139.2 million, which was up 25.68% from -$187.4 million recorded in Q2 2025.
- Over the past 5 years, Ptc Therapeutics' Invested Capital peaked at $325.7 million during Q1 2021, and registered a low of -$1.1 billion during Q4 2024.
- Over the past 3 years, Ptc Therapeutics' median Invested Capital value was -$651.0 million (recorded in 2023), while the average stood at -$626.9 million.
- Per our database at Business Quant, Ptc Therapeutics' Invested Capital slumped by 525.26% in 2023 and then surged by 86.56% in 2025.
- Quarterly analysis of 5 years shows Ptc Therapeutics' Invested Capital stood at $151.0 million in 2021, then tumbled by 282.10% to -$274.9 million in 2022, then slumped by 190.38% to -$798.4 million in 2023, then tumbled by 35.21% to -$1.1 billion in 2024, then surged by 86.56% to -$139.2 million in 2025.
- Its Invested Capital was -$139.2 million in Q3 2025, compared to -$187.4 million in Q2 2025 and -$166.9 million in Q1 2025.